Fig. 3From: Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practiceKaplan–Meier curves. Event-free survival over time for statistically significant log-rank testsBack to article page